Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Atorvastatin 80 mg vs Lipitor 80 mg in Healthy Thai Volunteers (Fasting, Replicate Crossover)
TCTR20200120004Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of atorvastatin in hypercholesterolemia and dyslipidemia (2 arms), sponsored by Bio-innova. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on TCTR20200120004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200120004.